Zhan H, Quinn M, Tian W, Yan L, et al. Significance of Removing Comedonecrosis as an Exclusion Criterion in Mammary Low-Risk Ductal Carcinoma In Situ Managed in an Active Surveillance Clinical Trial. Am J Clin Pathol 2021;156:596-606.
PMID: 33769445